Contrast in Pregnancy and Lactation
Practical recommendations and ready-to-use report text on iodinated and gadolinium contrast use in pregnant and lactating women (ACR, CBR, ACOG).

Interactive Checklist
Answer the questions in order. The checklist applies ACR, CBR and ACOG criteria for contrast use in pregnant and lactating women.
Iodinated and gadolinium contrast in pregnancy and lactation
The recommendation changes depending on the scenario (pregnant or lactating) and contrast type (iodinated or gadolinium). Practical summary based on ACR, CBR, and ACOG:
Pregnant + iodinated contrast
ACR does not recommend withholding iodinated contrast in pregnant women when necessary for diagnostic purposes. Document clinical justification and consent.
Pregnancy: iodinated contrast may be administered when clinically necessary and when diagnostic benefit outweighs theoretical risks, with documented justification.
Pregnant + gadolinium
Exceptional use: discuss risk/benefit and obtain consent. When necessary, prefer more stable agents (Group II, predominantly macrocyclic) and the lowest diagnostic dose possible.
Pregnancy: routine gadolinium should be avoided; consider only in exceptional situations, with relevant clinical benefit and shared decision-making.
Lactating + iodinated contrast
Interruption of breastfeeding is not necessary after intravenous iodinated contrast.
Breastfeeding: no need to interrupt after intravenous iodinated contrast.
Lactating + gadolinium
Interruption of breastfeeding is generally not necessary after gadolinium-based contrast — less than 0.04% of the maternal dose is excreted in milk.
Breastfeeding: generally no need to interrupt after gadolinium-based contrast.
Premedication for prior allergic reaction
Patient with history of allergic reaction to contrast: premedication is recommended per institutional protocol. Do not omit premedication when indicated.
Outside pregnancy/lactation
For non-pregnant and non-lactating patients, use the institutional routine contrast protocol.